EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Metabolic Dysfunction-Associated Steatotic Liver Disease and Risk of Hepatocellular Carcinoma in Type 2 Diabetes Mellitus

So Hyun Cho, Gyuri Kim, Kyu-Na Lee, Rosa Oh, Ji Yoon Kim, Myunghwa Jang, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Kyungdo Han, Jae Hyeon Kim

Diabetes & Metabolism Journal · 2025

DOI: 10.4093/dmj.2024.0641 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes & Metabolism Journal, 2025. Verfasst von So Hyun Cho und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Diabetes Mellitus, Type 2, Liver Neoplasms, Fatty Liver. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We investigated the incidence rates of hepatocellular carcinoma (HCC) in metabolic dysfunction-associated steatotic liver disease (MASLD) categories, focusing on its association with alcohol consumption in patients with type 2 diabetes mellitus (T2DM).

Methods

This study included 2,418,858 patients with T2DM aged 20 years and older who underwent a health examination between 2009 and 2012. Participants were categorized into five groups according to hepatic steatosis, cardiometabolic risk factors, other liver diseases, and alcohol consumption. Hepatic steatosis was defined as the fatty liver index ≥30. Cox regression analysis was used to analyze the association between steatotic liver disease and development of HCC.

Results

The MASLD group showed a higher risk of HCC development regardless of alcohol consumption or presence of other liver diseases (adjusted hazard ratio [aHR], 1.38; 95% confidence interval [CI], 1.33 to 1.44). The MASLD with other combined group expressed the highest risk (aHR, 5.02; 95% CI, 4.79 to 5.27). In the metabolic dysfunction and alcohol-related steatotic liver disease and alcohol-related liver disease groups, heavy to excessive alcohol consumption increased the risk of HCC development, with a higher risk associated with greater alcohol intake (aHR, 2.40; 95% CI, 2.27 to 2.53 and aHR, 3.16; 95% CI, 2.93 to 3.41). Fine and Gray analysis also exhibited a consistent trend.

Conclusion

MASLD in patients with T2DM was associated with an increased risk of developing HCC, particularly when accompanied by other liver diseases. Moreover, alcohol consumption proportionally increased the risk of HCC with the amount of alcohol consumed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularDiabetes Mellitus, Type 2Liver NeoplasmsFatty LiverHumansMaleFemaleMiddle AgedRisk FactorsAdultAgedIncidenceAlcohol Drinking

Stichwörter der Autor:innen

Alcohol drinkingCarcinoma, hepatocellularDiabetes mellitusFatty liver

Autor:innen und Institutionen

  • Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Department of Statistics and Actuarial Science, Soongsil University, Seoul, Korea.
  • Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, Korea.

Zitieren

APA

Cho, S. H., Kim, G., Lee, K. N., Oh, R., Kim, J. Y., Jang, M., Lee, Y. B., Jin, S. M., Hur, K. Y., Han, K., & Kim, J. H. (2025). Metabolic Dysfunction-Associated Steatotic Liver Disease and Risk of Hepatocellular Carcinoma in Type 2 Diabetes Mellitus. Diabetes & Metabolism Journal. https://doi.org/10.4093/dmj.2024.0641

Vancouver

Cho SH, Kim G, Lee KN, Oh R, Kim JY, Jang M, et al. Metabolic Dysfunction-Associated Steatotic Liver Disease and Risk of Hepatocellular Carcinoma in Type 2 Diabetes Mellitus. Diabetes & Metabolism Journal. 2025. doi:10.4093/dmj.2024.0641

BibTeX
@article{Cho2025,
  author = {Cho, So Hyun and Kim, Gyuri and Lee, Kyu-Na and Oh, Rosa and Kim, Ji Yoon and Jang, Myunghwa and Lee, You-Bin and Jin, Sang-Man and Hur, Kyu Yeon and Han, Kyungdo and Kim, Jae Hyeon},
  title = {Metabolic Dysfunction-Associated Steatotic Liver Disease and Risk of Hepatocellular Carcinoma in Type 2 Diabetes Mellitus},
  journal = {Diabetes & Metabolism Journal},
  year = {2025},
  doi = {10.4093/dmj.2024.0641}
}
Kostenlos starten →